Pfizer’s European Manufacturing Vulnerable to Potential US Tariffs, CEO Warns
Pfizer CEO Albert Bourla stated that the company's manufacturing operations in Europe are vulnerable to potential US tariffs on the European Union14.
Pfizer has at least 10 manufacturing plants across Europe, including facilities in Ireland, Spain, Germany, and Sweden14.
The company's manufacturing operations in China, Canada, and Mexico are not likely to be affected by current tariff measures14.
President Donald Trump has threatened to impose a 25% tariff on pharmaceutical imports, which could take effect as early as April 2, 20252.
The proposed tariffs could disrupt global pharmaceutical supply chains, increase production costs, and potentially lead to drug shortages5.
European Union officials have engaged in discussions with the Trump administration to address trade concerns and potential tariff impacts6.
The pharmaceutical industry relies heavily on globally integrated supply chains, with the US importing a substantial volume of APIs and finished medicines5.
Industry organizations are advocating for exemptions for critical medicines and APIs to mitigate potential negative impacts on healthcare systems and patients5.
Pfizer is currently implementing a Manufacturing Optimization Program aimed at reducing costs and improving gross margin performance4.
The potential tariffs could affect not only Pfizer but also other major pharmaceutical companies with significant manufacturing presence in Europe25.
Sources:
1. https://www.irishexaminer.com/business/companies/arid-41577400.html
2. https://www.euronews.com/business/2025/02/19/trump-raises-threat-of-higher-tariffs-on-more-goods-into-the-us
4. https://www.pharmamanufacturing.com/industry-news/news/55269058/pfizer-ceo-says-companys-manufacturing-is-vulnerable-to-us-threat-of-european-tariffs
5. https://www.europeanpharmaceuticalreview.com/article/248998/how-could-tariffs-impact-the-pharmaceutical-industry/
6. https://www.pbs.org/newshour/world/eu-trade-commissioner-meets-with-trump-administration-counterparts-over-tariff-threats